Tinitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1: Participants must have a confirmed diagnosis of subjective tinnitus that has persisted for at least six months. 2: The tinnitus occurs in the bilateral ears. 3: No restrictions on gender; participants must be aged between 18 and 60. 4: Participants must be able to comply with the study protocol and sign a written informed consent form. 5: Participants must not be currently enrolled in any other clinical trials.
Exclusion criteria
Exclusion criteria: 1: Participants diagnosed with objective tinnitus 2: Participants with neurological or neuropsychiatric conditions that may interfere with fNIRS results, such as acoustic neuroma, traumatic brain injury and cerebrovascular disease 3: Participants with severe cardiovascular or cerebrovascular disease, malignant liver or kidney disease, or other life-threatening conditions 4: Participants with any contraindications to acupuncture (e.g. a tendency to bleed) 5: Pregnant or breastfeeding women 6: Participants who have undergone tinnitus treatment with medication or other therapeutic methods within the past four weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tinnitus Handicap Inventory;Psychoacoustic tests of tinnitus (tinnitus pitch and loudness matching); | — |
Secondary
| Measure | Time frame |
|---|---|
| fNIRS measurements: Oxygenated hemoglobin (HbO) and inter-regional resting-state functional connectivity (RSFC) strength;**Pure-tone audiometry (PTA)**; | — |
Countries
China
Contacts
Zhejiang Rehabilitation Medical Centre